☆ 4.6 Letter

Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma

CANCER MEDICINE (2021)

Get Full Text
Add to Collection

Journal

CANCER MEDICINE
Volume 10, Issue 20, Pages 6933-6936

Publisher

WILEY
DOI: 10.1002/cam4.4254

Keywords

mass spectrometry; multiple myeloma; NGF-MRD

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.